[1] Zhang Y, Ren JS, Shi JF, et al. International trends in primary liver cancer incidence from 1973 to 2007. BMC Cancer, 2015, 15(1):94-104. [2] 杨海青, 孙伟娜. TACE治疗PLC患者血清肿瘤标志物水平变化. 实用肝脏病杂志, 2018, 21(1):123-124. [3] Zhang DW, Xu AX. Application of dual-source CT perfusion imaging and MRI for the diagnosis of primary liver cancer. Oncol Lett, 2017, 14(5):5753-5758. [4] Cong WM, Wu MC. New insights into molecular diagnostic pathology of primary liver cancer: Advances and challenges. Cancer Lett, 2015, 368(1):14-19. [5] Gabriel M, Tomczak J, Snochziókiewicz M, et al. Superb micro-vascular imaging (SMI): a Doppler ultrasound technique with potential to identify, classify, and follow up endoleaks in patients after endovascular aneurysm repair (EVAR). Abdom Radiol, 2018, 43(12):3479-3486. [6] 中华人民共和国卫生部. 原发性肝癌诊疗规范(2011年版). 中华肝脏病杂志, 2012, 20(6):929-946. [7] Karavias D, Kourea H, Sotiriadi A, et al. Gangrenous cholecystitis related to transcatheter arterial chemoembolization (TACE) treatment for hepatocellular carcinoma.J Gastrointest Surg, 2015, 19(11):2093-2095. [8] Huang W, You L, Yang S, et al. Metronomic S-1 chemotherapy plus transcatheter arterial chemoembolization (TACE): a promising treatment of hepatocellular carcinoma refractory to TACE. J Buon, 2016, 21(4):909-916. [9] Ha TY, Hwang S, Lee YJ, et al. Absence of benefit of transcatheter arterial chemoembolization (TACE) in patients with resectable solitary hepatocellular carcinoma.World J Surg, 2015, 40(5):1200-1210. [10] Ai N, Liu W, Li ZG, et al. High expression of GP73 in primary hepatocellular carcinoma and its function in the assessment of transcatheter arterial chemoembolization.Oncol Lett, 2017, 14(4):3953-3958. [11] Maki S, Konno T, Maeda H. Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium. Cancer, 2015, 56(4):751-757. [12] Yang K, Cheng YS, Yang JJ, et al. Primary hepatic neuroendocrine tumors: multi-modal imaging features with pathological correlations.Cancer Imaging, 2017, 17(1):20-26. [13] Dong Y, Zhu Z, Wang WP, et al. Ultrasound features of hepatocellular adenoma and the additional value of contrast-enhanced ultrasound. Hepatobiliary Pancreat Dis Int, 2016, 15(1):48-54. [14] Park AY, Seo BK, Cha SH, et al. An innovative ultrasoundtechnique for evaluation of tumor vascularity in breast cancers: superb micro-vascular imaging. J Breast Cancer, 2016, 19(2):210-213. [15] 刘水清, 马一博, 韩宗宏, 等. 超微细血流成像技术评价肝癌介入治疗疗效的价值. 中华肝脏病杂志, 2017, 25(7):512-516. [16] Kong SH, Yue XW, Kong S, et al. Application of contrast-enhanced ultrasound and enhanced CT in diagnosis of liver cancer and evaluation of radiofrequency ablation.Oncol Lett, 2018, 16(2):2434-2438. [17] Durmaz MS, Sivri M. Comparison of superb micro-vascular imaging (SMI) and conventional Doppler imaging techniques for evaluating testicular blood flow.J Med Ultrason, 2018, 45(3):443-452. [18] 杨志军, 赵丽娟. 超声超微细彩色血管成像技术评价经肝动脉化疗栓塞治疗的原发性肝癌患者肿瘤血供效能初步应用研究. 实用肝脏病杂志, 2018, 21(4):509-512. [19] Lee DH, Lee JY, Han JK. Superb microvascular imaging technology for ultrasound examinations: Initial experiences for hepatic tumors. Eur J Radiol, 2016, 85(11):2090-2095. [20] Liao M, Zhu Z, Wang H, et al. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis. Scand J Gastroenterol, 2017, 52(6):624-634. |